NM_170682.4:c.774+7C>G
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_170682.4(P2RX2):c.774+7C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000355 in 1,527,748 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_170682.4 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 41Inheritance: AD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00169 AC: 257AN: 151758Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.000516 AC: 128AN: 248018 AF XY: 0.000372 show subpopulations
GnomAD4 exome AF: 0.000207 AC: 285AN: 1375870Hom.: 1 Cov.: 43 AF XY: 0.000165 AC XY: 113AN XY: 686928 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00169 AC: 257AN: 151878Hom.: 0 Cov.: 34 AF XY: 0.00155 AC XY: 115AN XY: 74260 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
774+7C>G in intron 7 of P2RX2: This variant is not expected to have clinical sig nificance because it is not located within the conserved splice consensus sequen ce. It has been identified in 0.6% (27/4404) of African American chromosomes fro m a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washin gton.edu/EVS; dbSNP rs199743808). -
The P2RX2 c.672+2C>G variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs199743808) and ClinVar (reported as benign by Invitae and Laboratory for Molecular Medicine). The variant was identified in control databases in 184 of 279412 chromosomes at a frequency of 0.0006585 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 166 of 24874 chromosomes (freq: 0.006674) and Latino in 18 of 35382 chromosomes (freq: 0.000509), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish), Other, or South Asian populations. The c.672+2C>G variant is predicted to cause abnormal splicing because the nucleotide substitution occurs in the invariant region of the splice consensus sequence. However, only three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing. Further, on other P2RX2 transcripts this variant does not fall within the splicing consensus sequence. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. -
not provided Benign:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at